Drugs / Soluble Corn Fiber
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02916862 | Feb 2020 → Apr 2025 | osteoporosis | Florida International University | Completed | No outcome recorded |
| Phase 2 | NCT03673618 | Sep 2019 → Dec 2021 | childhood onset asthma | Phoenix Children's Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Soluble Corn Fiber | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02916862 ↗ |
| Known as | PROMOTIR | “Participants will ingest PROMOTIR soluble corn fiber (85% fiber, 12 g/day) in a fruit-flavored beverage for 4 weeks alongside their normal diet and normal asthma treatments.” NCT03673618 ↗ |
| Known as | SCF | “This is a double-blind, placebo-controlled trial of children who were randomized to consume 12 g of soluble corn fiber (SCF) as a supplement to their usual daily diet (50% the...” PMID 41647190 ↗ Jan 20261“Soluble Corn Fiber (SCF) + Calcium” NCT02916862 ↗ |